TY - JOUR AU - Mollick, Tanzina AU - LaĆ­n, Sonia PY - 2020 DA - 2020/06/09 TI - Modulating pyrimidine ribonucleotide levels for the treatment of cancer JO - Cancer & Metabolism SP - 12 VL - 8 IS - 1 AB - By providing the necessary building blocks for nucleic acids and precursors for cell membrane synthesis, pyrimidine ribonucleotides are essential for cell growth and proliferation. Therefore, depleting pyrimidine ribonucleotide pools has long been considered as a strategy to reduce cancer cell growth. Here, we review the pharmacological approaches that have been employed to modulate pyrimidine ribonucleotide synthesis and degradation routes and discuss their potential use in cancer therapy. New developments in the treatment of myeloid malignancies with inhibitors of pyrimidine ribonucleotide synthesis justify revisiting the literature as well as discussing whether targeting this metabolic pathway can be effective and sufficiently selective for cancer cells to warrant an acceptable therapeutic index in patients. SN - 2049-3002 UR - https://doi.org/10.1186/s40170-020-00218-5 DO - 10.1186/s40170-020-00218-5 ID - Mollick2020 ER -